バイオ医薬品物流市場レポート：2030年までの動向、予測、競合分析

バイオ医薬品物流の動向と予測

世界のバイオ医薬品物流市場は、2024～2030年のCAGRが7.5%で、2030年までに推定1,292億米ドルに達すると予想されます。この市場の主要促進要因は、精密医薬品や遺伝子治療の増加、家庭用医療アイテムの需要拡大、物流業務のアウトソーシング傾向の増大です。世界のバイオ医薬品物流市場の将来は、製薬、バイオ医薬品、薬局、病院、クリニック、スーパーマーケットの各市場における機会で有望視されています。

Lucintelの予測では、コールドチェーン物流は、温度管理された製品へのニーズが高まっており、商品の有効性を確保するために正確な温度管理物流サービスが必要となるため、予測期間中に高い成長が見込まれています。

この市場の中では、医薬品が予測期間中に最も高い成長を遂げると予想されています。

北米は、同地域における医薬品の輸出入が拡大しているため、予測期間中も最大地域であり続けると考えられます。

バイオ医薬品物流市場の新たな動向

市場ニーズに変化をもたらした先端技術は、バイオ医薬品物流市場における効率性、コンプライアンス、サービス品質の向上という主要動向を牽引しています。この命題に関連して最も一般的に観察されている動向には、以下のようなものがあります。

• 高度なコールドチェーン技術：先進的なコールドチェーン技術：IoTセンサーや自動温度制御システムなど、先進的なコールドチェーン技術が開発されており、サプライチェーンを通じて厳格な温度要件を維持する能力が強化されています。また、温度に敏感なバイオ医薬品の完全性と有効性を確保し、腐敗の可能性を減らし、規制当局の基準に適合できるようにします。
• ブロックチェーン技術の統合：バイオ医薬品物流は、トレーサビリティと完全な透明性を高める方法でブロックチェーン技術を統合しようとしています。ブロックチェーンは、取引と製品の移動に関する永続的な記録を記載しています。ブロックチェーンは偽造を防止し、記録の正確性を向上させ、サプライチェーンを通じてバイオ医薬品製品の真正性と安全性を保証します。AIと自動化の応用最近の人工知能は、在庫管理、ルートプランニング、予知保全など、物流・オペレーションの最適化にますます応用されています。人工知能と自動化は、業務効率を高め、人的ミスを減らし、コスト削減のための意思決定を強化する一方で、配送スケジュールの信頼性を向上させる。
• バイオ医薬品におけるeコマースの成長：eコマースの成長は、バイオ医薬品の物流に影響を与え始めています。この動向は、ラストマイル配送ソリューションを含む新たな配送方法への物流・プロバイダーの適応と、患者直送便特有の課題に対応できるシステムの導入を必要としています。
• 規制遵守の強化：温度管理、文書化、報告に関する要件など、さまざまな地域における厳格な規制基準を完全に遵守することに高い関心が払われています。規制遵守の強化は、より複雑な物流ソリューションの進化につながり、より詳細な文書化と、バイオ医薬品の安全性と品質を保証する国際基準への準拠が求められます。
• このような動向は、サプライチェーンをより効果的で透明性の高いものにし、規制に準拠させることで、バイオ医薬品物流市場展望を大きく変えつつあります。技術開発が日進月歩を続ける中、こうした新たな動向は、バイオ医薬品に対する世界中の絶え間なく変化するニーズに対応するため、業界内の革新と適応の領域をさらに拡大することになると考えられます。
• バイオ医薬品物流市場の最近の動向
• バイオ医薬品物流市場の最近の動向は、技術の進歩、規制の変更、産業界のニーズの変化に後押しされています。
• コールドチェーンの革新：先進温度制御パッケージングやIoTベースのモニタリングシステムなど、コールドチェーン技術の大幅な強化により、バイオ医薬品の物流サービスの信頼性が向上しています。これらの技術革新により、温度に敏感な製品は、その完全性を維持するために最適な条件下で維持・輸送され、腐敗やコンプライアンス上の問題を最小限に抑えることができます。
• デジタル化とリアルタイム追跡：物流の様相は、デジタルツールとリアルタイム追跡システムの世界へと徐々に変貌しつつあります。RFIDとGPSは、貨物の位置と状態の両方を追跡するために導入されている技術の一部です。リアルタイムの追跡は、サプライチェーンの可視性を向上させ、予想される混乱へのタイムリーな介入と管理を可能にします。
• 物流ネットワークの拡大：物流・ネットワークは拡大しつつあり、新たな物流センターの設置や、より優れた輸送インフラの整備へとシフトしています。拡大されたネットワークの利点は、世界経済における製品の需要を満たすため、より速いペースで製品を流通させる効率を確保できることです。
• AIと機械学習の採用：AIと機械学習技術は、需要予測、ルート最適化、在庫管理など、物流業務の最適化を可能にする方法で採用されています。これらの技術は、業務効率の向上、コスト削減、物流・プロセス管理の精度向上に寄与します。
• 規制への適応：バイオ医薬品の物流における新たな課題は、温度管理や文書管理を改善する上で、規制の枠組みにとって中心的な課題となっています。規制への適応は、より高いレベルの安全性と品質基準を保証し、より高度な物流ソリューションを開発することを目的としています。
• このような動向は、バイオ医薬品物流市場における業務効率、コンプライアンス、全体的なサービス品質の向上に大きく貢献しています。こうした発展は、バイオ医薬品業界の新たなニーズをサポートし、同市場の物流業務にさらなる信頼性をもたらすと考えられます。
• バイオ医薬品物流市場の戦略的成長機会
• バイオ医薬品物流市場は、技術革新とともに高度な物流ソリューションに対する需要の高まりを示す、いくつかの異なるアプリケーションから様々な戦略的成長機会を提示しています。
• コールドチェーン管理：高度なコールドチェーン管理ソリューションへの投資は、大きな成長機会をもたらします。アクティブ冷却システムやリアルタイムモニタリングなどの技術は、温度に敏感な製品の完全性を保証することができます。改善されたコールドチェーン管理は、生物製剤や個別化医療に対する需要の高まりに対応するため、廃棄物を最小限に抑えながら、医薬品を非常に狭い温度制限範囲内に確実にとどめるのに役立ちます。
• eコマースと患者直送：eコマースや患者直送モデルの動向の高まりに伴い、専門の物流・プロバイダーに新たな機会が生まれています。効率的なラストマイル配送ソリューションを開発することで、在宅治療の動向に対応することができます。この成長セグメントでは、利便性と直接配達のオプションが求められます。このようなオプションには、複雑な配送要件や患者とのやりとりに対応できる物流ソリューションが必要となります。
• 高度なデータ分析：物流の業務において高度なデータ分析の力を活用することは、明確な成長機会です。分析は、需要予測、ルート計画、さらには在庫管理においてより良い仕事をするため、物流業務をさらに最適化します。データ分析能力の向上は、効率的な物流業務、無駄な経費の削減、より良い意思決定につながり、バイオ医薬品業界全体の成長を促進します。
• 自動化とロボティクス：物流業務に自動化とロボティクスを導入することで、より大きな成長の余地があります。倉庫管理、仕分け、輸送の自動化システムは、より効率的で正確なものとなります。自動化は人為的ミスを減らすことでオペレーションコストを削減し、物流プロセスのスピードを向上させるため、円滑なオペレーションを行うために企業が行うべき有望な投資となります。
• 規制遵守ソリューション：絶え間なく進化する規制基準へのコンプライアンスを提供するソリューションを確保することで、成長の道が開ける。これには、技術による追跡、報告、品質基準の維持が含まれます。コンプライアンスソリューションは、物流・プロバイダーが厳格な規制を満たしながら、コンプライアンス違反に伴うリスクを低減し、バイオ医薬品の配送における安全性と生産性を確保するのに役立ちます。
• このような新たな成長機会は、新たなニーズの特定と開拓、または技術的進歩による成果によって、バイオ医薬品物流市場の今後の方向性を決めることになると考えられます。バイオ医薬品物流の革新と信頼性を伴うさらなる効率化は、市場が進化するにつれて、これらの新たな機会によって推進されます。
• バイオ医薬品物流市場促進要因・課題
• 技術的、経済的、規制的な要因がいくつか存在し、これらはバイオ医薬品物流市場の成長を促進すると同時に、重要な課題も提示しています。主要促進要因としては、技術的進歩やバイオ医薬品需要の増加が挙げられるが、導入コストの高さ、データセキュリティ、複雑な規制への対応などが顕著な課題として挙げられます。このような力学を知ることは、利害関係者が市場を効果的に横断し、機会を活用して障害を克服する上で有益です。
• バイオ医薬品ロジスティック市場を牽引する要因には、以下のようなものがあります。

1.技術の進歩：IoT、AI、ブロックチェーンは、バイオ医薬品物流セグメントに革命をもたらす幅広い技術の一部です。IoTセンサーは温度をより正確にリアルタイムで監視し、AIはルートプランニングと在庫管理を最適化し、ブロックチェーンはチェーンのすべてのリンクを高度に透明化し、追跡可能にします。これらの強化により、効率性が向上し、エラーの可能性が減り、温度に敏感な出荷の完全性が高まります。そのため、より洗練された物流ソリューションへの需要に応え、最終的にはサプライチェーンをより信頼性の高い効率的なものにするのに役立ちます。

2.バイオ医薬品需要の増加：医療研究の進歩、慢性疾患の有病率の上昇、世界人口の高齢化により、生物製剤や個別化医薬品のようなバイオ医薬品の需要が増加することは明らかです。それに応じて、複雑なサプライチェーンを管理できる、より専門的な物流を必要とする高価値の製品が増えています。

3.世界のサプライチェーンの拡大別利益：サプライチェーンのグローバリゼーションは、強固なバイオ医薬品物流ソリューションの必要性を生み出しています。企業は国際市場に進出する一方で、国境を越えた出荷を管理し、様々な規制基準を確実に満たすことのできる物流ネットワークを必要としています。効率的な世界の物流ソリューションは、タイムリーな配送を可能にし、混乱を軽減します。これは、バイオ医薬品の製品パイプラインの流れを維持し、世界中の顧客ベースの要件を満たすために必要です。

• バイオ医薬品物流市場における課題は以下の通りです：

1.技術導入コストの高さ：IoTシステムやブロックチェーンなどの先進技術は、導入コストが非常に高いです。コストには、一時的な技術投資、継続的なメンテナンス、既存システムとの統合などが含まれます。これらは、小規模な物流業者にとっては、参入障壁となり、非常にコストがかかるため、ハイテクソリューションを提供する可能性が制限される可能性があります。これは、大手と中小の市場参入企業の間にある種のデジタルデバイドをもたらす可能性があります。

2.データ・プライバシーとセキュリティの問題：バイオ医薬品物流における大きな課題の一つは、機密性の高い医療情報をいかに保護するかということです。データのプライバシーとセキュリティを保証するには、適切なサイバーセキュリティ対策とGDPRやHIPAAなどの様々な規制の遵守が必要です。データ漏洩やセキュリティの失敗は、法的紛争や信頼の失墜、罰金につながる可能性があります。こうした問題に対処するには、セキュリティ技術やプロセスへの多額の投資が必要となります。

3.当局へのコンプライアンスの複雑さ：バイオ医薬品企業向けの物流プロバイダーにとって、地域別異なる規制環境は実に深刻な問題です。取り扱い、文書化、輸送に関する規制は国によって異なる可能性があります。関連するすべての規制を遵守するには、膨大な知識とリソースが必要です。コンプライアンス違反は、遅延、罰金、市場アクセスの問題につながる可能性があります。

• バイオ医薬品物流市場の主要促進要因には、技術開発、需要の拡大、規制要件などがあり、業務効率化と世界サプライチェーンは大きな利益をもたらします。しかし、導入コストの高さ、データセキュリティへの懸念、複雑な規制遵守に関する問題は、この市場の欠点として作用します。利害関係者が市場の進化に合わせて動き、成長とイノベーションの機会を活用するためには、こうした市場促進要因・課題のバランスが鍵となります。
• バイオ医薬品ロジスティック企業リスト
• 同市場の企業は、提供する製品の品質で競争しています。この市場の主要企業は、製造施設の拡大、研究開発投資、インフラ開拓、バリューチェーン全体の統合機会の活用に注力しています。こうした戦略を通じて、バイオ医薬品物流企業は需要の増加に対応し、競合を確保し、革新的な製品と技術を開発し、製造コストを削減し、顧客基盤を拡大しています。本レポートで紹介するバイオ医薬品物流企業は以下の通りです。
• Kuehne+Nagel
• C.H. Robinson
• United Parcel Service
• Deutsche Post DHL
• Panalpina World Transport

目次

第1章 エグゼクティブサマリー

第2章 世界のバイオ医薬品物流市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018～2030年の市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界のバイオ医薬品物流市場の動向（2018～2023年）と予測（2024～2030年）
• 製品タイプ別の世界のバイオ医薬品物流市場
  • コールドチェーン物流
  • 非コールドチェーン物流
• 輸送サービスタイプ別の世界のバイオ医薬品物流市場
  • 輸送
  • 倉庫と保管
• 最終用途別の世界のバイオ医薬品物流市場
  • 医薬品
  • バイオ医薬品
  • 薬局
  • 病院
  • クリニック
  • スーパーマーケット
  • その他

第4章 2018～2030年の地域別市場動向と予測分析

• 地域別のバイオ医薬品物流市場
• 北米のバイオ医薬品物流市場
• 欧州のバイオ医薬品物流市場
• アジア太平洋のバイオ医薬品物流市場
• その他地域のバイオ医薬品物流市場

第5章 競合分析

• 製品ポートフォリオ分析
• 業務統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 製品タイプ別の世界のバイオ医薬品物流市場の成長機会
  • 輸送サービスタイプ別の世界のバイオ医薬品物流市場の成長機会
  • 最終用途別の世界のバイオ医薬品物流市場の成長機会
  • 地域別の世界のバイオ医薬品物流市場の成長機会
• 世界のバイオ医薬品物流市場における新たな動向
• 戦略分析
  • 新製品開発
  • 世界のバイオ医薬品物流市場の能力拡大
  • 世界のバイオ医薬品物流市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Kuehne+Nagel
• C.H. Robinson
• United Parcel Service
• Deutsche Post DHL
• Panalpina World Transport

Biopharmaceutical Logistic Trends and Forecast

The future of the global biopharmaceutical logistic market looks promising with opportunities in the pharmaceutical, biopharmaceutical, pharmacy, hospital, clinic, and supermarket markets. The global biopharmaceutical logistic market is expected to reach an estimated $129.2 billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are rising number of precision medicines and gene therapies, growing demand for household healthcare items, and augmenting trend of outsourcing logistical operations.

Lucintel forecasts that cold chain logistic is expected to witness the higher growth over the forecast period due to its increasing need for temperature-controlled products, necessitating precise temperature control logistics services to ensure the efficacy of the goods.

Within this market, pharmaceutical is expected to witness the highest growth over the forecast period.

North America will remain the largest region over the forecast period due to expanding number of pharmaceuticals export and importation activity in the region.

Emerging Trends in the Biopharmaceutical Logistic Market

The advanced technologies that have caused a change in the landscape of market needs have driven the key trends of improving efficiency, compliance, and service quality in the biopharmaceutical logistics market. Some of the most prevailing observed trends in relation to the said proposition include:

• Advanced Cold Chain Technologies : Advanced cold chain technologies are being developed-including IoT sensors and automated temperature control systems-that enhance the capability to maintain strict temperature requirements through the supply chain. Besides, it ensures the integrity and effectiveness of temperature-sensitive biopharmaceutical products, lessening the potential for spoilage and making sure that they are able to conform to regulatory authority standards.
• Integration of Blockchain Technology: Biopharmaceutical logistics is going to integrate blockchain technology in ways that enhance traceability and total transparency. It provides a permanent record of transactions and product movements. Blockchain prevents counterfeits, improves record accuracy, and guarantees the authenticity and safety of a biopharmaceutical product through the supply chain. The applications of AI and Automation Description: Artificial Intelligence in recent times is finding its applications increasingly in optimizing logistics operation-inventory management, route planning, predictive maintenance. Artificial intelligence and automation raise operational efficiency, reduce human errors, and enhance decision-making for cost savings, while the reliability of delivery schedules is improved.
• Growth of E-commerce in Biopharma: Growth in e-commerce has begun to impact how the logistics of biopharmaceuticals work, particularly with regard to an increased demand for direct-to-patient delivery models and home-based treatments. The trend requires the adaptation of logistics providers to new methods of delivery, including last-mile delivery solutions, and to implement systems that can handle the unique challenges of direct-to-patient shipments.
• Increased Regulatory Compliance: High attention is being paid to making sure there is complete compliance with strict regulatory standards in various regions, including requirements in regard to temperature control, documentation, and reporting. Better regulatory compliance leads to the evolution of more complex logistics solutions, requiring more detailed documentation and compliance with international standards that ensure the safety and quality of biopharmaceutical products.
• These trends are restructuring the outlook of the biopharmaceutical logistics market by making supply chains more effective, transparent, and regulatory compliant. As technological development continues to keep pace, these emerging trends will further extend the area of innovation and adaptation within the industry as it meets the continuously changing needs around the world for biopharmaceuticals.
• Recent Developments in the Biopharmaceutical Logistic Market
• Recent developments in the biopharmaceutical logistics market are powered by technological advances, changes in regulations, and changing industrial needs.
• Cold Chain Innovation: There is great enhancement in cold chain technology, such as advanced temperature-controlled packaging and IoT-based monitoring systems, that raise the bar for the dependability of logistics services for biopharmaceuticals. These innovations ensure that temperature-sensitive products are maintained and transported under conditions optimal for preserving their integrity, thereby minimizing spoilage and compliance issues.
• Digitalization and Real-Time Tracking: The face of logistics is gradually metamorphosing into a world of digital tools and real-time tracking systems. RFID and GPS are some of the technologies being implemented to track both the location and condition of shipments. Real-time tracking improves supply chain visibility for timely intervention and management of expected disruptions.
• Expansion of Logistics Networks: Logistics networks are expanding, and there is a shift toward setting up new distribution centers and developing better transportation infrastructure. The advantages of extended networks are that it ensures the efficiency of distributing the products at a faster pace to meet the demand of the product in the global economy.
• Adoption of AI and Machine Learning: AI and machine learning technologies are being adopted in ways that enable the logistics operations to be optimized, including demand forecasting, route optimization, and inventory management. These technologies contribute to increased operational efficiency, cost reduction, and heightened accuracy in the management of logistics processes.
• Regulatory Adaptations: New challenges within the biopharmaceutical logistics have been the central issue for regulatory frameworks in improving controls over temperature and documentation. The adaptation to regulations aims at assuring even higher levels of safety and quality standards, developing more advanced logistics solutions.
• These trends drive a lot of improvements in operational efficiencies, compliances, and overall service quality in the biopharmaceutical logistics market. These advancement developments will support the emerging needs of the biopharmaceutical industry and provide further reliability to logistics operations in this market.
• Strategic Growth Opportunities for Biopharmaceutical Logistic Market
• The biopharmaceutical logistics market presents various strategic growth opportunities from several different applications, showcasing an increasing demand for advanced logistics solutions along with technological innovations.
• Cold Chain Management: Investment in advanced cold chain management solutions presents a significant growth opportunity. Technologies such as active cooling systems and real-time monitoring can ensure the integrity of temperature-sensitive products. Improved cold chain management helps ensure drugs remain within very narrow ranges of temperature limits, with minimization of waste to supply the rising demand for biologics and personalized medicine.
• E-commerce and Direct-to-Patient Delivery: With the increasing trend of e-commerce and direct-to-patient delivery models, new opportunities arise for specialized logistics providers. Efficient last-mile delivery solutions can be developed to help deal with the growing trend of home-based treatments. With this growth area comes demand for convenience and direct delivery options. Such an option would require logistics solutions that can handle complex delivery requirements and patient interactions.
• Advanced Data Analytics: Leveraging the power of advanced data analytics in the operations of logistics is an explicit growth opportunity. Analytics will further optimize logistics operations, as it would do a better job in demand forecasting, route planning, and even inventory management. Improved capabilities in data analytics will lead to efficient logistics operations, less wastage of money, and better decision-making, hence promoting the overall growth of the biopharmaceutical industry.
• Automation and Robotics : There is a huge scope for higher growth by introducing automation and robotics into logistics operations. Automated systems for warehousing, sorting, and transportation can be much more efficient and accurate. Automation reduces operation costs by reducing human errors and increases the speed of the logistics processes, hence becoming a promising investment to be undertaken by companies for smooth operations.
• Regulatory Compliance Solutions: Ensuring solutions that offer compliance with regulatory standards in constant evolution opens up an avenue of growth. It includes tracking, reporting, and maintaining quality standards through technology. Compliance solutions help logistics providers meet rigorous regulations while reducing risks associated with non-compliance and ensuring safety and productivity in the delivery of biopharmaceutical products.
• These emerging growth opportunities will be the future direction of the biopharmaceutical logistics market, either by identification and development of emerging needs or results through technological advancements. Innovation and further efficiency with reliability in biopharmaceutical logistics are driven by these emerging opportunities as the market is evolving.
• Biopharmaceutical Logistic Market Driver and Challenges
• Several technological, economic, and regulatory factors prevail, which drive the growth of the biopharmaceutical logistics market while presenting its significant set of challenges. Key drivers include technological advancement and increasing demand for biopharmaceuticals, while high implementation costs, data security, and complex regulatory compliance are some of the notable challenges. Being aware of these dynamics will thus be useful for the stakeholders in effectively traversing the market and leveraging opportunities to overcome obstacles.
• The factors responsible for driving the biopharmaceutical logistic market include:

1. Technological Advancement: IoT, AI, and blockchain are part of a wide range of technologies that can revolutionize the biopharmaceutical logistics sector. IoT sensors monitor temperature more precisely and in real time, while AI optimizes route planning and inventory management; blockchain makes every link in the chain highly transparent and traceable. These enhancements result in better efficiency, less chance for errors, and greater integrity of temperature-sensitive shipments. Therefore, they help to meet the demand for more sophisticated logistics solutions and, finally, make supply chains more reliable and efficient.

2. Increase in Demand for Biopharmaceuticals: The demand is evidently going to rise for biopharmaceutical products such as biologics and personalized medicines due to advancements in medical research, rising prevalence of chronic diseases, and an ageing global population. Correspondingly, there are an increasing number of high-value products requiring more specialized logistics that can manage the complexities of these supply chains, not least stringent temperature control and handling requirements.

3. The Gains from an Expanded Global Supply Chain: The globalization of supply chains has created the need for robust biopharmaceutical logistics solutions. Companies, while expanding into international markets, require logistics networks that are able to manage cross-border shipments and ensure that the variety of regulatory standards is met. Efficient global logistics solutions enable timely delivery and reduce disruptions-necessary to keep the biopharmaceutical product pipeline flowing and help meet the requirements of a worldwide customer base.

• Challenges in the biopharmaceutical logistic market are:

1. High Costs of Technology Implementation: Advanced technologies, such as IoT systems and blockchain, are very expensive to adopt. The costs include one-time technology investments, continuous maintenance, and integrations with existing systems. These could be entrance barriers and very costly for smaller logistics providers, therefore limiting their potential to provide high-tech solutions. This might lead to a certain digital divide between big and small market players.

2. Data Privacy and Security Issues: One of the major challenges in biopharmaceutical logistics is how to safeguard sensitive health information. Assuring data privacy and security requires proper cybersecurity measures and adherence to various regulations such as GDPR and HIPAA. Data breaches and security failures could result in legal disputes, a loss of trust, and fines. Addressing these issues requires heavy investment in security technologies and processes.

3. Complexity of Compliance with Authorities: The varied regulatory environments of different regions are indeed serious to work through for logistics providers catering to biopharmaceutical companies. Regulations pertaining to handling, documentation, and transportation could be different from country to country. Compliance with all relevant regulations requires enormous knowledge and resources. Noncompliance may lead to delays, fines, or problems of market access.

• Key drivers in the biopharmaceutical logistics market include technological development, growth in demand, and regulatory requirements, while operational efficiency and global supply chains significantly benefit. However, issues regarding high implementation costs, data security concerns, and complex regulatory compliance act as drawbacks to this market. The balance between such drivers and challenges is key for stakeholders to move with the evolution of the market and leverage opportunities for growth and innovation.
• List of Biopharmaceutical Logistic Companies
• Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies biopharmaceutical logistic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biopharmaceutical logistic companies profiled in this report include-
• Kuehne + Nagel
• C.H. Robinson
• United Parcel Service
• Deutsche Post DHL
• Panalpina World Transport
• Biopharmaceutical Logistic by Segment
• The study includes a forecast for the global biopharmaceutical logistic by product type, transport service type, end use, and region.

Biopharmaceutical Logistic Market by Product Type [Analysis by Value from 2018 to 2030]:

• Cold Chain Logistics
• Non-Cold Chain Logistic

Biopharmaceutical Logistic Market by Transport Service Type [Analysis by Value from 2018 to 2030]:

• Transportation
• Warehouse and Storage

Biopharmaceutical Logistic Market by End Use [Analysis by Value from 2018 to 2030]:

• Pharmaceuticals
• Biopharmaceuticals
• Pharmacies
• Hospitals
• Clinics
• Supermarkets

Biopharmaceutical Logistic Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World
• Country Wise Outlook for the Biopharmaceutical Logistic Market
• Changes in regulation, technological innovations, and shifts in global demand are some of the factors that make the pace of the biopharmaceutical logistics market very fast. This particular market niche has become pivotal for safe and timely drug delivery, as a result of the nature of most biopharmaceutical products, which are sensitive either to temperature or handling conditions. Recent developments reflect the advancement of technology, increasing demand for specialized logistics solutions, and adaptation to regulatory changes across major global markets.
• United States: In the U.S., cold chain solutions are increasingly becoming advanced, integrated with digital tracking technologies. The adoption of IoT and blockchain is improving the transparency and real-time monitoring of supply chains. Regulations are changing to aim for improved compliance with safety standards, while surging demand is noticed in logistics services due to a rise in personalized medicines and biologics.
• China: The Chinese biopharmaceutical logistics market is growing rapidly due to increased focus on healthcare modernization. Investors are building basic infrastructures like temperature-controlled warehouses and advanced logistics networks. China is still at a nascent stage in developing regulations, but its government is gradually making such legislation more stringent to ensure higher quality and safety standards, thus fostering further development in this segment with increasingly sophisticated logistics solutions.
• Germany: Automation and digitization keep pace for a better service performance in German biopharmaceutical logistics. It builds high-tech warehouses to serve the customers better and develops smart transportation solutions. The strict European Union regulations are observed on the front line, with cold-chain integrity and traceability features of biopharmaceutical products.
• India: With more emphasis on infrastructure improvement and integration of technology, the Indian biopharmaceutical logistics market is growing. Specialized logistics providers offering cold chain solutions to meet the demand at the local level continue to rise in this country. Added to that, there is pressure to develop better regulatory compliance and quality control that meets international standards in support of the rapid growth of the pharmaceutical industry.
• Japan: The integration of robotics and AI to enhance efficiency and accuracy for Japan is witnessing an upsurge in biopharmaceutical logistics. Thereby, the market bears accomplished cold chain management systems along with an elevated amount of regulatory scrutiny. Japanese logistics providers are also focused on improving their digital solutions to enable better inventory management and smoothening the supply chain.
• Features of the Global Biopharmaceutical Logistic Market
• Market Size Estimates: Biopharmaceutical logistic market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
• Segmentation Analysis: Biopharmaceutical logistic market size by product type, transport service type, end use, and region in terms of value ($B).
• Regional Analysis: Biopharmaceutical logistic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different product types, transport service types, end uses, and regions for the biopharmaceutical logistic market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biopharmaceutical logistic market.
• Analysis of competitive intensity of the industry based on Porter's Five Forces model.
• If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
• FAQ
• Q1. What is the biopharmaceutical logistic market size?
• Answer: The global biopharmaceutical logistic market is expected to reach an estimated $129.2 billion by 2030.
• Q2. What is the growth forecast for biopharmaceutical logistic market?
• Answer: The global biopharmaceutical logistic market is expected to grow with a CAGR of 7.5% from 2024 to 2030.
• Q3. What are the major drivers influencing the growth of the biopharmaceutical logistic market?
• Answer: The major drivers for this market are rising number of precision medicines and gene therapies, growing demand for household healthcare items, and augmenting trend of outsourcing logistical operations.
• Q4. What are the major segments for biopharmaceutical logistic market?
• Answer: The future of the biopharmaceutical logistic market looks promising with opportunities in the pharmaceutical, biopharmaceutical, pharmacy, hospital, clinic, and supermarket markets.
• Q5. Who are the key biopharmaceutical logistic market companies?

Answer: Some of the key biopharmaceutical logistic companies are as follows:

• Kuehne + Nagel
• C.H. Robinson
• United Parcel Service
• Deutsche Post DHL
• Panalpina World Transport
• Q6. Which biopharmaceutical logistic market segment will be the largest in future?
• Answer: Lucintel forecasts that cold chain logistic is expected to witness the higher growth over the forecast period due to its increasing need for temperature-controlled products, necessitating precise temperature control logistics services to ensure the efficacy of the goods.
• Q7. In biopharmaceutical logistic market, which region is expected to be the largest in next 5 years?
• Answer: North America will remain the largest region over the forecast period due to expanding number of pharmaceuticals export and importation activity in the region.
• Q.8 Do we receive customization in this report?
• Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the biopharmaceutical logistic market by product type (cold chain logistics and non-cold chain logistic), transport service type (transportation and warehouse and storage), end use (pharmaceuticals, biopharmaceuticals, pharmacies, hospitals, clinics, supermarkets, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global Biopharmaceutical Logistic Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Biopharmaceutical Logistic Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Biopharmaceutical Logistic Market by Product Type
  • 3.3.1: Cold Chain Logistics
  • 3.3.2: Non-Cold Chain Logistic
• 3.4: Global Biopharmaceutical Logistic Market by Transport Service Type
  • 3.4.1: Transportation
  • 3.4.2: Warehouse and Storage
• 3.5: Global Biopharmaceutical Logistic Market by End Use
  • 3.5.1: Pharmaceuticals
  • 3.5.2: Biopharmaceuticals
  • 3.5.3: Pharmacies
  • 3.5.4: Hospitals
  • 3.5.5: Clinics
  • 3.5.6: Supermarkets
  • 3.5.7: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Biopharmaceutical Logistic Market by Region
• 4.2: North American Biopharmaceutical Logistic Market
  • 4.2.1: North American Biopharmaceutical Logistic Market by Product Type: Cold Chain Logistics and Non-Cold Chain Logistic
  • 4.2.2: North American Biopharmaceutical Logistic Market by End Use: Pharmaceuticals, Biopharmaceuticals, Pharmacies, Hospitals, Clinics, Supermarkets, and Others
• 4.3: European Biopharmaceutical Logistic Market
  • 4.3.1: European Biopharmaceutical Logistic Market by Product Type: Cold Chain Logistics and Non-Cold Chain Logistic
  • 4.3.2: European Biopharmaceutical Logistic Market by End Use: Pharmaceuticals, Biopharmaceuticals, Pharmacies, Hospitals, Clinics, Supermarkets, and Others
• 4.4: APAC Biopharmaceutical Logistic Market
  • 4.4.1: APAC Biopharmaceutical Logistic Market by Product Type: Cold Chain Logistics and Non-Cold Chain Logistic
  • 4.4.2: APAC Biopharmaceutical Logistic Market by End Use: Pharmaceuticals, Biopharmaceuticals, Pharmacies, Hospitals, Clinics, Supermarkets, and Others
• 4.5: ROW Biopharmaceutical Logistic Market
  • 4.5.1: ROW Biopharmaceutical Logistic Market by Product Type: Cold Chain Logistics and Non-Cold Chain Logistic
  • 4.5.2: ROW Biopharmaceutical Logistic Market by End Use: Pharmaceuticals, Biopharmaceuticals, Pharmacies, Hospitals, Clinics, Supermarkets, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Biopharmaceutical Logistic Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Biopharmaceutical Logistic Market by Transport Service Type
  • 6.1.3: Growth Opportunities for the Global Biopharmaceutical Logistic Market by End Use
  • 6.1.4: Growth Opportunities for the Global Biopharmaceutical Logistic Market by Region
• 6.2: Emerging Trends in the Global Biopharmaceutical Logistic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Biopharmaceutical Logistic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biopharmaceutical Logistic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Kuehne + Nagel
• 7.2: C.H. Robinson
• 7.3: United Parcel Service
• 7.4: Deutsche Post DHL
• 7.5: Panalpina World Transport